Elliot Israel Elliot Israel is the Gloria and Anthony Simboli Distinguished Professor in Asthma Research and Professor of Medicine at Harvard Medical School (Boston, MA, USA), and the Director of Clinical Research in the Pulmonary and Critical Care Division at the Brigham and Women’s Hospital (Boston, MA, USA). He directs the Brigham and Women’s Hospital Severe Asthma Program. Elliot Israel received his medical degree from the Johns Hopkins University School of Medicine (Baltimore, MD, USA). He completed training in internal medicine at the Johns Hopkins Hospital and Weill Cornell Medical Center at the New York- Presbyterian Hospital (formerly New York Hospital New York, NY, USA). He undertook fellowships in pulmonary and critical care medicine and allergy and immunology at Harvard Medical School. He is board-certified in allergy and immunology, pulmonary medicine, critical care medicine and internal medicine. Elliot Israel’s research interests include severe asthma, using precision medicine to optimise therapeutic interventions, pharmacogenetic influences on treatment responses, and the role of fatty acid metabolites in asthma pathobiology. He leads a US federally funded study to test novel interventions to narrow disparities in asthma outcomes. At Brigham and Women’s Hospital, he is principal investigator of a USA National Institutes of Health-funded initiative to advance precision medicine using adaptive design techniques to identify novel treatments for severe asthma. He leads the protocol design committee of that initiative. Elliot Israel has authored over 200 peer-reviewed publications and is member of the USA National Asthma Education and Prevention Program (NAEPP) Committee examining asthma guidelines. He is the recipient of the Harvard Medical School Daniel D. Federman Outstanding Clinical Educator Award. Peter G. Gibson Peter G. Gibson works as a doctor who cares for people with respiratory diseases and as a clinical scientist investigating the mechanisms and treatment of asthma, COPD, cough and other airway disorders. He is a concept leader who has developed innovative approaches around: inflammatory subtypes of asthma and cough airway biomarkers neurogenic mechanisms, laryngeal dysfunction and related treatments for refractory cough multidimensional https://doi.org/10.1183/2312508X.10019519 vii
Previous Page Next Page